Univest
Univest
  • Markets

Vimta Labs Q1 Results FY27: Net Profit Rises 11.37% to Rs 21 Cr as Revenue Grows 11.8%

  • July 21, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Vimta Labs Q1 Results

Vimta Labs Q1 FY27: PAT Rs 21 Cr (+11.37% YoY), revenue Rs 109 Cr (+11.8%). Stock fell 5.18% to Rs 530.25 on 20 July 2026.

Vimta Labs Q1 results FY27 are out. The company reported a standalone net profit of Rs 21 Cr for the quarter ended 30 June 2026, up 11.37% from Rs 18 Cr in the year ago quarter, in results announced on Monday, 20 July 2026.

Shares of Vimta Labs fell 5.18% to Rs 530.25 on the results day. The company is a contract research, testing and certification laboratory.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Vimta Labs Q1 Results FY27 Key Takeaways
  • Vimta Labs Q1 Results FY27 Financial Highlights
  • Vimta Labs Q1 Results FY27 Performance Analysis
  • Vimta Labs Q1 Results FY27: Key Business Factors
    • 1. Topline Momentum
    • 2. Operating Performance
    • 3. Bottom Line Delivery
  • Dividend Details
  • Vimta Labs Q1 Results FY27 Outlook for the Full Year
  • Vimta Labs Stock Performance After the Q1 Results
  • Key Risks
    • 1. Sustaining the Growth Rate
    • 2. Margin Durability
    • 3. Execution and External Risks
  • Conclusion
  • Frequently Asked Questions on Vimta Labs Q1 Results FY27
    • When were the Vimta Labs Q1 results FY27 announced?
    • What is the PAT in the Vimta Labs Q1 results FY27?
    • What was the revenue in the Vimta Labs Q1 results FY27?
    • What was the gross profit in the Vimta Labs Q1 results FY27?
    • Are the Vimta Labs Q1 results FY27 standalone or consolidated?
    • How did the share price react after the Vimta Labs Q1 results FY27?
    • Is the stock a good buy after the Vimta Labs Q1 results FY27?
    • Where can I verify the Vimta Labs Q1 results FY27?

Vimta Labs Q1 Results FY27 Key Takeaways

Here are the most important numbers from the June 2026 quarter at a glance.

  • Net Profit (PAT): Rs 21 Cr in Q1 FY27 versus Rs 18 Cr in Q1 FY26, a change of +11.37% year on year.
  • Revenue: Rs 109 Cr in Q1 FY27 versus Rs 97 Cr in Q1 FY26, a change of +11.8%.
  • Gross Profit: Rs 24 Cr in Q1 FY27 versus Rs 23 Cr in Q1 FY26, a change of +3.92%.
  • Results announced on Monday, 20 July 2026 for the quarter ended 30 June 2026 on a standalone basis.
  • Vimta Labs share price fell 5.18% to Rs 530.25 on the results day.

Vimta Labs Q1 Results FY27 Financial Highlights

The table below summarises the standalone numbers reported in the Vimta Labs Q1 results FY27 against the year ago quarter.

Metric Q1 FY27 Q1 FY26 YoY Change
Revenue Rs 109 Cr Rs 97 Cr +11.8%
Gross Profit Rs 24 Cr Rs 23 Cr +3.92%
Net Profit (PAT) Rs 21 Cr Rs 18 Cr +11.37%

All figures are on a standalone basis as reported for the quarter ended 30 June 2026.

Vimta Labs Q1 Results FY27 Performance Analysis

Get Personalised Guidance from a SEBI-Registered Investment Advisor

Profit growth is the headline of the Vimta Labs Q1 results FY27. Revenue grew 11.8% to Rs 109 Cr from Rs 97 Cr. Gross profit rose 3.92% to Rs 24 Cr from Rs 23 Cr.

The broad based improvement across revenue, gross profit and net profit in the Vimta Labs Q1 results FY27 suggests the quarter’s growth is operational rather than driven by one off items.

Vimta Labs Q1 Results FY27: Key Business Factors

1. Topline Momentum

Revenue grew 11.8% to Rs 109 Cr from Rs 97 Cr. This sets the base against which the rest of the P&L in the Vimta Labs Q1 results FY27 should be read.

2. Operating Performance

Gross profit rose 3.92% to Rs 24 Cr from Rs 23 Cr. The gross profit trend is the cleanest read on operating health in the quarter.

3. Bottom Line Delivery

The net result of Rs 21 Cr captures the combined effect of operations, other income, finance costs and tax for the quarter.

Dividend Details

Any dividend announcement accompanying the June 2026 quarter results will be reflected in the company’s official NSE and BSE filings. Investors should rely on those filings for dividend confirmation rather than secondary sources.

Vimta Labs Q1 Results FY27 Outlook for the Full Year

The Vimta Labs Q1 results FY27 set the tone for FY27. The next markers are the September quarter numbers, any guidance from management, and how costs and demand evolve through the festive half of the year.

Vimta Labs Stock Performance After the Q1 Results

Download the Univest iOS App or Univest Android App to track Vimta Labs live share price and upcoming quarterly results.

Vimta Labs share price fell 5.18% to Rs 530.25 on the results day, as the market weighed the quarter’s numbers against expectations.

Investors can compare the trend of the counter with the Nifty 500 index to judge how the stock is placed relative to the broader market after the June quarter results.

Key Risks

Investors going through the fine print of the Vimta Labs Q1 results FY27 should also weigh the following risks.

1. Sustaining the Growth Rate

The growth reported in the Vimta Labs Q1 results FY27 sets a higher base for coming quarters, and any moderation could disappoint a market that extrapolates.

2. Margin Durability

Whether the quarter’s operating performance holds depends on input costs, pricing power and mix, all of which can shift quickly.

3. Execution and External Risks

Demand cycles, regulatory changes and sector specific shocks remain outside management control and can reset expectations.

Conclusion

Vimta Labs Q1 results FY27 show standalone net profit of Rs 21 Cr for the quarter ended 30 June 2026, up 11.37% from Rs 18 Cr in the year ago quarter. Revenue grew 11.8% to Rs 109 Cr from Rs 97 Cr. The September quarter will show whether this quarter’s trend extends. Investors should verify the filings on NSE and BSE and consult a SEBI-registered advisor before acting on the numbers.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Vimta Labs Q1 Results FY27

When were the Vimta Labs Q1 results FY27 announced?

Ans. The Vimta Labs Q1 results FY27 were announced on Monday, 20 July 2026, for the quarter ended 30 June 2026, on a standalone basis.

What is the PAT in the Vimta Labs Q1 results FY27?

Ans. The standalone PAT in the Vimta Labs Q1 results FY27 stood at Rs 21 Cr, a change of +11.37% from Rs 18 Cr in Q1 FY26.

What was the revenue in the Vimta Labs Q1 results FY27?

Ans. The revenue in the Vimta Labs Q1 results FY27 stood at Rs 109 Cr, a change of +11.8% from Rs 97 Cr in Q1 FY26.

What was the gross profit in the Vimta Labs Q1 results FY27?

Ans. Gross profit for the June 2026 quarter stood at Rs 24 Cr, compared with Rs 23 Cr in Q1 FY26, a change of +3.92% year on year.

Are the Vimta Labs Q1 results FY27 standalone or consolidated?

Ans. The figures discussed here are on a standalone basis, as reported for the quarter ended 30 June 2026.

How did the share price react after the Vimta Labs Q1 results FY27?

Ans. Vimta Labs share price fell 5.18% to Rs 530.25 on the results day.

Is the stock a good buy after the Vimta Labs Q1 results FY27?

Ans. The Vimta Labs Q1 results FY27 are one input among many. Valuation, sector conditions and risk appetite matter as much as a single quarter. This article is for educational purposes only. Consult a SEBI-registered advisor before investing.

Where can I verify the Vimta Labs Q1 results FY27?

Ans. The official filings for the Vimta Labs Q1 results FY27 are available on the NSE and BSE websites, and the stock can be tracked on the Univest app.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply